n(6)-benzyladenosine has been researched along with Bladder Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldoli, E; Casati, S; Ciuffreda, P; Maier, JA; Ottria, R | 1 |
| Casati, S; Castiglioni, S; Ciuffreda, P; Maier, JA; Ottria, R | 1 |
2 other study(ies) available for n(6)-benzyladenosine and Bladder Cancer
| Article | Year |
|---|---|
N⁶-Alkyladenosines: Synthesis and evaluation of in vitro anticancer activity.
Topics: Adenosine; Antineoplastic Agents; Cell Line, Tumor; Cytokinins; Humans; Metalloproteases; Urinary Bladder Neoplasms | 2010 |
N6-isopentenyladenosine and its analogue N6-benzyladenosine induce cell cycle arrest and apoptosis in bladder carcinoma T24 cells.
Topics: Adenosine; Antineoplastic Agents; Apoptosis; Cell Cycle; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Isopentenyladenosine; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2013 |